1. Home
  2. MMS vs VCYT Comparison

MMS vs VCYT Comparison

Compare MMS & VCYT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Maximus Inc.

MMS

Maximus Inc.

N/A

Current Price

$53.98

Market Cap

3.2B

ML Signal

N/A

Logo Veracyte Inc.

VCYT

Veracyte Inc.

N/A

Current Price

$44.68

Market Cap

3.2B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MMS
VCYT
Founded
1975
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Business Services
Medical Specialities
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.2B
3.2B
IPO Year
1997
2013

Fundamental Metrics

Financial Performance
Metric
MMS
VCYT
Price
$53.98
$44.68
Analyst Decision
Buy
Buy
Analyst Count
2
13
Target Price
★ $92.50
$58.42
AVG Volume (30 Days)
548.7K
★ 1.2M
Earning Date
11-19-2026
11-03-2026
Dividend Yield
★ 2.48%
N/A
EPS Growth
10.42
★ 164.52
EPS
★ 5.45
0.66
Revenue
★ $2,392,236,000.00
N/A
Revenue This Year
N/A
$14.82
Revenue Next Year
$2.89
$11.24
P/E Ratio
★ $9.78
$70.03
Revenue Growth
N/A
★ N/A
52 Week Low
$51.04
$29.46
52 Week High
$100.00
$60.91

Technical Indicators

Market Signals
Indicator
MMS
VCYT
Relative Strength Index (RSI) 47.70 54.89
Support Level $53.19 $40.03
Resistance Level $60.42 $50.54
Average True Range (ATR) 1.55 2.40
MACD -0.17 0.71
Stochastic Oscillator 47.22 70.80

Price Performance

Historical Comparison
MMS
VCYT

About MMS Maximus Inc.

Maximus Inc designs, develops, and delivers programs enabling people to access vital government services. It translates health and human services public policy into operating models that achieve outcomes for governments at scale. The company covers a broad array of services, including the operation of large health insurance eligibility and enrollment programs; clinical services, including assessments, appeals, and independent medical reviews; and technology services. The company operates through the following segments: U.S. Federal Services, U.S. Services, and Outside the U.S. A majority of its revenue is derived from the U.S. Federal Services segment, which engages with various U.S. federal government agencies to deliver clinical services, maintenance services, and technology solutions.

About VCYT Veracyte Inc.

Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder).

Share on Social Networks: